MedTrace Logo

Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis

NCT01553006 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2012-03-14

No results posted yet for this study

Summary

Cefditoren pivoxil has been used in rhinosinusitis treatment. However, little is known about the efficacy of this drug at low and high doses.

Conditions

  • Rhinosinusitis

Interventions

DRUG

cefditoren pivoxil

comparison of different dosages of cefditoren pivoxil

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • Orapan Poachanukoon, MD. · Thammasat University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-08-31
Completion
2012-09-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01553006 on ClinicalTrials.gov